Intervertebral Disc Augmentation With Minimally Invasive Surgical Procedure
| Status: | Completed |
|---|---|
| Conditions: | Orthopedic |
| Therapuetic Areas: | Orthopedics / Podiatry |
| Healthy: | No |
| Age Range: | Any |
| Updated: | 11/18/2012 |
| Start Date: | March 2011 |
| End Date: | March 2015 |
| Contact: | Michael Mac Millan, M.D. |
| Email: | macmim@ortho.ufl.edu |
| Phone: | (352) 273-7016 |
Intervertebral Disc Nucleus Augmentation With Allograft Meniscus With Minimally Invasive Surgical Procedure
The primary purpose of the study is to establish the degree and duration of pain relief
following minimally invasive surgery for a painful degenerative disc.
The investigators will study patient recovery (outcome measures) in patients who have had
minimally invasive surgery for implantation of human meniscus allograft (HMA) to replace the
nucleus pulposus of a degenerative intervertebral disc.
Inclusion Criteria:
- diagnosis of degenerative disk disease at L3-L4, L4-L5, or L5-S1
- low back for no more that one year prior to enrollment
Exclusion Criteria:
- Osteoporosis
- Degenerative changes of vertebral endplates (obvious fractures, osteophytes)
- Modic Type II changes indicative of advanced bony degeneration
- Facet arthrosis (loss of facet joint cartilage, increased synovial fluid collection,
or presence of osteophytes in inferior or superior plates)
- Discs classified with stage I or II degeneration
- Patients unable to have an MRI (pacemaker, claustrophobia, etc.)
We found this trial at
1
site
Click here to add this to my saved trials
